| OSBP |
OSBP, OSBP1: Oxysterol-binding protein 1 |
MAPKAPK2 |
MAPKAPK2: MAP kinase-activated protein kinase 2 |
0.265 |
Evidence |
|
| BGN |
BGN: Biglycan precursor |
COL15A1 |
COL15A1: Collagen alpha-1(XV) chain precursor [Contains: Endostatin |
0.265 |
Evidence |
|
| BGN |
BGN: Biglycan precursor |
GDF15 |
GDF15, MIC1, PDF, PLAB, PTGFB: Growth/differentiation factor 15 precursor |
0.265 |
Evidence |
|
| BGN |
BGN: Biglycan precursor |
IGFBP5 |
IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor |
0.265 |
Evidence |
|
| BGN |
BGN: Biglycan precursor |
IGFBP6 |
IGFBP6, IBP6: Insulin-like growth factor-binding protein 6 precursor |
0.265 |
Evidence |
|
| BGN |
BGN: Biglycan precursor |
IGFBP4 |
IGFBP4, IBP4: Insulin-like growth factor-binding protein 4 precursor |
0.265 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
F11R |
F11R, JAM1, UNQ264/PRO301, JCAM: Junctional adhesion molecule A precursor |
0.265 |
Evidence |
|
| TAF1 |
TAF1, BA2R, CCG1, CCGS, TAF2A: Transcription initiation factor TFIID subunit 1 |
CDX2 |
CDX2, CDX3: Homeobox protein CDX-2 |
0.265 |
Evidence |
|
| TAF1 |
TAF1, BA2R, CCG1, CCGS, TAF2A: Transcription initiation factor TFIID subunit 1 |
MYST4 |
MYST4, KIAA0383, MORF, MOZ2: Histone acetyltransferase MYST4 |
0.265 |
Evidence |
|
| FLNA |
FLNA, FLN, FLN1: Filamin-A |
CIB1 |
CIB1, CIB, KIP, PRKDCIP: Calcium and integrin-binding protein 1 |
0.265 |
Evidence |
|
| FLNA |
FLNA, FLN, FLN1: Filamin-A |
S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
0.265 |
Evidence |
|
| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
ICOSLG |
ICOSLG, B7H2, B7RP1, ICOSL, KIAA0653: ICOS ligand precursor |
0.265 |
Evidence |
|
| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
ADAM19 |
ADAM19, MLTNB, FKSG34: ADAM 19 precursor |
0.265 |
Evidence |
|
| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
0.265 |
Evidence |
|
| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
CD80 |
CD80, CD28LG, CD28LG1, LAB7: T-lymphocyte activation antigen CD80 precursor |
0.265 |
Evidence |
|
| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
0.265 |
Evidence |
|
| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
0.265 |
Evidence |
|
| C4BPB |
C4BPB: C4b-binding protein beta chain precursor |
PCOLCE |
PCOLCE, PCPE1: Procollagen C-endopeptidase enhancer 1 precursor |
0.265 |
Evidence |
|
| LMNB1 |
LMNB1, LMN2, LMNB: Lamin-B1 |
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
0.265 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
ICOSLG |
ICOSLG, B7H2, B7RP1, ICOSL, KIAA0653: ICOS ligand precursor |
0.265 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
MPP6 |
MPP6, VAM1: MAGUK p55 subfamily member 6 |
0.265 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
ADAM19 |
ADAM19, MLTNB, FKSG34: ADAM 19 precursor |
0.265 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
CD80 |
CD80, CD28LG, CD28LG1, LAB7: T-lymphocyte activation antigen CD80 precursor |
0.265 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
0.265 |
Evidence |
|
| CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.265 |
Evidence |
|